AtTEnd/ENGOT-EN7
Trial Description:
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Endometrial
Trial Status:
Closed to Recruitment
Contact person:
ncolombo